Recently, it was reported that disruption of the NLRP3 inflammasome, which reduces conversion of pro-IL-1β to mature IL-1β, among other actions, ameliorates the phenotype of both mouse models of amyloidosis [15] and models of tauopathy [16]. This evidence concerns the gene NLRP3 and amyloidosis.